CL
ICPT

CSS LLC’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

CSS LLC’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,000
Closed -$81K – 1294
2022
Q1 		$81K Buy
5,000
+4,400
+733% +$68.9K ﹤0.01% 961
2021
Q4 		$10K Buy
+600
New +$10.1K ﹤0.01% 1210
2021
Q2 		– Sell
-10,800
Closed -$249K – 1206
2021
Q1 		$249K Sell
10,800
-37,300
-78% -$1.04M 0.01% 719
2020
Q4 		$1.19M Buy
48,100
+21,300
+79% +$706K 0.05% 291
2020
Q3 		$1.11M Buy
26,800
+5,000
+23% +$230K 0.05% 271
2020
Q2 		$1.04M Buy
21,800
+200
+0.9% +$15.4K 0.06% 257
2020
Q1 		$1.36M Hold
21,600
– – 0.11% 173
2019
Q4 		$2.68M Buy
21,600
+14,300
+196% +$1.28M 0.15% 131
2019
Q3 		$485K Buy
7,300
+7,200
+7,200% +$483K 0.03% 319
2019
Q2 		$8K Sell
100
-3,500
-97% -$313K ﹤0.01% 791
2019
Q1 		$403K Buy
+3,600
New +$393K 0.02% 338
2018
Q1 		– Sell
-13,500
Closed -$788K – 635
2017
Q4 		$788K Hold
13,500
– – 0.04% 271
2017
Q3 		$783K Hold
13,500
– – 0.04% 270
2017
Q2 		$1.64M Buy
13,500
+5,000
+59% +$579K 0.08% 180
2017
Q1 		$962K Buy
8,500
+3,500
+70% +$409K 0.06% 226
2016
Q4 		$543K Buy
+5,000
New +$596K 0.03% 331

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

CSS LLC's ICPT Position: Q2 2022 in Review

CSS LLC sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2022, closing a stake of 5,000 shares — an estimated $81K sold.

CSS LLC first reported a position in ICPT in Q1 2017 and held it in 8 quarters. The position peaked at $549K in Q4 2017. 144 funds tracked by Wall St. Rank hold ICPT as of Q2 2022.

  • CSS LLC reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • CSS LLC sold 5,000 Intercept Pharmaceuticals, Inc. shares in Q2 2022, an estimated $81K.
  • CSS LLC first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 8 quarters.
  • CSS LLC's Intercept Pharmaceuticals, Inc. position peaked at $549K in Q4 2017.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2022.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.